'Not Even Trace Quantities:' Tesla CEO Elon Musk Hits Back At Report Of Drug Use Allegations Worrying His Execs
Portfolio Pulse from Benzinga Neuro
Elon Musk refuted allegations of drug use reported by the Wall Street Journal, citing three years of clean random drug tests requested by NASA. The report had raised concerns among Tesla executives, with former director Linda Johnson Rice not seeking re-election to the board due to worries about Musk's substance use and behavior. Despite the controversy, Musk's leadership continues to drive progress at Tesla and SpaceX.
January 08, 2024 | 1:27 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Elon Musk's defense against drug use allegations and the report of executive concerns may affect investor sentiment towards Tesla, potentially impacting the stock price.
While Musk's defense may reassure some investors, the mention of executive concerns could create uncertainty. The impact on TSLA's stock price is likely to be mixed in the short term, as the market weighs the controversy against Tesla's strong performance and industry leadership.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80